174 results
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... medical diagrams, tables ... #pharmacology #table ... #comparison #medications ... #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... severe bleeding and ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
constitutional symptoms • Treatment ... Discontinuation of causal ... life-threatening • Treatment ... sle #comparison #table ... #rheumatology #
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Manifestations of Systemic Lupus ... autoantibodies that will cause ... Puncture, EEG Treatment ... CNS #neurology #rheumatology ... diagnosis #management #treatment
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison and ... #pharmacology #table ... #medications #comparison ... #drugs #treatment
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
concentration: > 750ng/mL and ... 200ng/mL Best indications ... • Special cases ... Measurement #SLE #rheumatology ... pharmacology #levels #lupus
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... Medications approved ... the long-term treatment ... mg #Obesity #Medications ... #Pharmacology #Table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... SLE) - Diagnosis and ... Positive in 60-80% of cases ... life-threatening • Treatment ... Management #Summary #rheumatology
Autoantibodies in Rheumatology
 • Lupus (SLE): ANA (anti-nuclear antibody), dsDNA (double-stranded DNA), Anti-Smith, Anti-Ro (SSA) and
Autoantibodies in Rheumatology ... • Lupus (SLE): ... Anti-Ro (SSA) and ... glycoprotein I (ß2GP), Lupus ... #associations #table
CERTA Analgesic Classes and Pain Indications

Dr. David H.Cisewski and Dr. Sergey M.Motov

#CERTA #Analgesic #Classes #Pain #Indications
CERTA Analgesic Classes ... and Pain Indications ... David H.Cisewski and ... #Pain #Indications ... #Management #Table